Watch VXRT. Know when insiders buy.
One email the day a filing lands. Free.
VXRT
Vaxart, Inc.
0.44
+0.00 +0.00%
USD · close Oct 2
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
52
WATCH · shorts 52
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $106.8MP/E 2.7DIV YIELD —FCF YIELD 31.24%REV TTM $243.1M +201.1%NET INCOME $38.6MNET CASH $4.3M52W 0.33 – 0.80SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $27.2M | −31.6% | — | −$13.2M | −$13.5M | — | -0.06 | $2.8M | $35K | $2.7M | Aug 6 |
| Q1 2026 · Mar 31 | $39.2M | +87.9% | — | $5.2M | $5.2M | — | 0.02 | −$2.1M | $448K | −$2.5M | May 7 |
| Q4 2025 · Dec 31derived | $104.2M | +586.5% | — | $55.4M | $55M | — | 0.24 | $30.7M | $1K | $30.7M | Mar 13 |
| Q3 2025 · Sep 30 | $72.4M | +1367.9% | — | −$7.8M | −$8.1M | — | -0.04 | $2.6M | $117K | $2.5M | Nov 13 |
| Q2 2025 · Jun 30 | $39.7M | +520.7% | — | −$14.6M | −$15M | — | -0.07 | −$15.9M | −$103K | −$15.8M | Aug 6 |
| Q1 2025 · Mar 31 | $20.9M | +857.2% | — | −$14.9M | −$15.6M | — | -0.07 | −$9.6M | $130K | −$9.7M | May 7 |
| Q4 2024 · Dec 31derived | $15.2M | +368.0% | — | −$11.5M | −$12M | — | -0.05 | −$7.3M | $44K | −$7.4M | Mar 13 |
| Q3 2024 · Sep 30 | $4.9M | +134.8% | — | −$14.5M | −$14.1M | — | -0.06 | −$4.2M | $9K | −$4.2M | Nov 13 |
| Q2 2024 · Jun 30 | $6.4M | — | — | −$16.3M | −$16.5M | — | -0.09 | −$12M | $370K | −$12.4M | Aug 13 |
| Q1 2024 · Mar 31 | $2.2M | — | — | −$24.1M | −$24.4M | — | -0.14 | −$21.2M | $131K | −$21.3M | May 13 |
| Q4 2023 · Dec 31derived | $3.2M | — | — | −$16.9M | −$17.4M | — | -0.12 | −$13.5M | −$104K | −$13.4M | Mar 20 |
| Q3 2023 · Sep 30 | $2.1M | — | — | −$17.8M | −$17.4M | — | -0.11 | −$15M | $282K | −$15.3M | Nov 13 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $237.3M | — | $18.1M | $16.3M | 6.9% | 0.07 | $7.7M | $145K | $7.6M | — | — |
| FY2024 · to Dec 31 | $28.7M | — | −$66.3M | −$66.9M | -233.3% | -0.33 | −$44.8M | $554K | −$45.3M | — | — |
| FY2023 · to Dec 31 | $7.4M | — | −$83.3M | −$82.5M | -1117.6% | -0.57 | −$70.5M | $1.9M | −$72.3M | — | — |
| FY2022 · to Dec 31 | — | — | −$114.6M | −$107.8M | — | -0.84 | −$94.8M | $9.6M | −$104.4M | — | — |
| FY2021 · to Dec 31 | — | — | −$72.8M | −$70.5M | — | -0.58 | −$59.8M | $5.2M | −$65M | — | — |
| FY2020 · to Dec 31 | — | — | −$30.2M | −$32.2M | — | -0.36 | −$23.8M | $1.2M | −$25M | — | — |
Every number comes from Vaxart, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.